Profitability
Weight: 20%
A
87
- 5yr Avg ROIC 26.3%
- Operating Margin Trend +0.06 pp/yr
INDV
Indivior Pharmaceuticals Inc
AlphaQuality composite grade, weighted for stable earnings power businesses.
⚠ 2 of the last 5 fiscal years showed negative net income — AlphaQuality will not grade above F for persistent unprofitability in a stable earnings power business.
Grade overrides the 30.0 pillar composite — hard gates always win.
Capital Efficiency
Weight: 15%
D+
41
- 5yr Avg ROE 0.0%
- 5yr Share-Count CAGR -4.6%
Growth Quality
Weight: 15%
B+
79
- 5yr Revenue CAGR 11.9%
- 5yr EPS CAGR 5.8%
- Revenue-Growth Years (5) 5/5
Cash Generation
Weight: 15%
C
54
- 5yr FCF Margin 0.0%
- 5yr FCF/NI Conversion 1.54x
Balance Sheet
Weight: 20%
A-
85
- Net Debt / EBITDA 0.51x
- Interest Coverage (EBIT/Int) 6.31x
- Altman Z-Score 3.93
Stability
Weight: 15%
D+
40
- EPS Volatility (σ/μ) 0.91
- Piotroski F-Score 4
- Negative-Revenue Years (5) 0/5
Guru Flow
Curated superinvestor sentiment — not part of the AlphaQuality grade.5 of 5 gurus held; 1 new buy; 2 added; 2 trimmed; 1 full exit.
- Holders
- 5
- Avg Δ position
- +424.6%
- New buys
- 1
- Full exits
- 1
- Soros sold -100%
- Dalio new
- Greenblatt increased +1774%